# Granules Pharmaceuticals Inc. - Inspection Records Source: https://www.keypedia.com/companies/granules-pharmaceuticals-inc/fa93bf3f-822e-47be-9e47-59b1c5446629 > Inspection records and compliance data for Granules Pharmaceuticals Inc. in Chantilly, Virginia. Access full analysis and detailed observations. --- ## Details - Name: Granules Pharmaceuticals Inc. - FEI Number: 3011585184 - City: Chantilly - State: Virginia - Country Name: United States - Address Line 1: 3701 Concorde Pkwy - Zip Code: 20151 - Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK, REPACK ## Related Documents - [483 - Granules Pharmaceuticals Inc. - 2026-04-03](https://www.keypedia.com/records/483/granules-pharmaceuticals-inc/d8b4fccb-5ec0-4d32-b070-267fbae547e0) — source: FDA, date: April 3, 2026 - [FDA Inspection 1311002 - Granules Pharmaceuticals Inc. - 2026-04-03](https://www.keypedia.com/records/fda_inspections/granules-pharmaceuticals-inc/920e888f-8fba-4596-ac5e-b8a55ca5eb4f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 3, 2026 - [483 - Granules Pharmaceuticals Inc. - 2025-06-27](https://www.keypedia.com/records/483/granules-pharmaceuticals-inc/ff217be2-7175-40cb-a94a-9d59b9094abe) — source: FDA, date: June 27, 2025 - [483 - Granules Pharmaceuticals Inc. - 2025-06-27](https://www.keypedia.com/records/483/granules-pharmaceuticals-inc/903c5e10-6a83-4038-a7fa-4a6b00d240b1) — source: FDA, date: June 27, 2025 - [FDA Inspection 1274604 - Granules Pharmaceuticals Inc. - 2025-06-27](https://www.keypedia.com/records/fda_inspections/granules-pharmaceuticals-inc/c26a7eea-057c-452e-9446-c4409110a57b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 27, 2025 - [483 - Granules Pharmaceuticals Inc. - 2023-12-15](https://www.keypedia.com/records/483/granules-pharmaceuticals-inc/ac2d6df3-5fe0-4df5-8fc5-fcd3805e2087) — source: FDA, date: December 15, 2023 - [FDA Inspection 1225087 - Granules Pharmaceuticals Inc. - 2023-12-15](https://www.keypedia.com/records/fda_inspections/granules-pharmaceuticals-inc/45371d19-7a67-4bab-ae38-48217349ea87) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 15, 2023 - [FDA Inspection 1215034 - Granules Pharmaceuticals Inc. - 2023-08-03](https://www.keypedia.com/records/fda_inspections/granules-pharmaceuticals-inc/f3a55b08-5f7e-4034-af92-ce1868eb2476) — classification: No Action Indicated (NAI), source: FDA, date: August 3, 2023 - [483 - Granules Pharmaceuticals Inc. - 2022-07-22](https://www.keypedia.com/records/483/granules-pharmaceuticals-inc/8b164ba2-7c87-4681-bcc0-c7ba8f6d66e7) — source: FDA, date: July 22, 2022 - [FDA Inspection 1175097 - Granules Pharmaceuticals Inc. - 2022-07-22](https://www.keypedia.com/records/fda_inspections/granules-pharmaceuticals-inc/d7966f15-715b-4405-88ac-c9e7d0d9e64c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 22, 2022 - [483 - Granules Pharmaceuticals Inc. - 2022-01-28](https://www.keypedia.com/records/483/granules-pharmaceuticals-inc/47bd023e-5880-46d4-9c5a-5d1a6a31f0be) — source: FDA, date: January 28, 2022 - [EIR - Granules Pharmaceuticals Inc. - 2022-01-28](https://www.keypedia.com/records/eir/granules-pharmaceuticals-inc/67f54236-78b9-4398-93b3-349428010285) — source: FDA, date: January 28, 2022 - [483 - Granules Pharmaceuticals Inc. - 2021-06-25](https://www.keypedia.com/records/483/granules-pharmaceuticals-inc/985739cb-3624-4fcf-be36-ae0504bddbf0) — source: FDA, date: June 25, 2021 - [483 - Granules Pharmaceuticals Inc. - 2020-01-17](https://www.keypedia.com/records/483/granules-pharmaceuticals-inc/9fe1058e-33b6-49d9-9426-06f3421359e1) — source: FDA, date: January 17, 2020 - [483 - Granules Pharmaceuticals Inc. - 2019-08-21](https://www.keypedia.com/records/483/granules-pharmaceuticals-inc/56ccf589-fc0f-403a-81ea-fef283c58c0d) — source: FDA, date: August 21, 2019 - [FDA Inspection 1035023 - Granules Pharmaceuticals Inc. - 2017-12-08](https://www.keypedia.com/records/fda_inspections/granules-pharmaceuticals-inc/365993a1-7a71-474c-9726-9ded32a3e0ca) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 8, 2017 ## Related Companies - [AACE Pharmaceuticals, Inc.](https://www.keypedia.com/companies/aace-pharmaceuticals-inc/96df8dd4-4462-4c9d-9874-1e1f004aad14) - [Roslin Cell Therapies Limited](https://www.keypedia.com/companies/roslin-cell-therapies-limited/284a8034-03ae-4031-906d-7603e297f7ab) - [Janssen Vaccines Corporation](https://www.keypedia.com/companies/janssen-vaccines-corporation/37824380-beec-4bdd-8b7d-a8441dfb6991) - [Kamada - Production Plant](https://www.keypedia.com/companies/kamada-production-plant/d3a7a962-b08c-4278-8951-5cad5bcfed41) - [Steri-Med Pharma Inc.](https://www.keypedia.com/companies/steri-med-pharma-inc/b7d1890a-851d-463f-8e30-4d8dd64d306f) - [RUBICON RESEARCH LIMITED](https://www.keypedia.com/companies/rubicon-research-limited/118f747f-e637-4112-bc70-6d016fdf3185) - [Hybio Pharmaceutical Co., Ltd. (Pingshan Factory)](https://www.keypedia.com/companies/hybio-pharmaceutical-co-ltd-pingshan-factory/a9645470-bf0e-4ade-9133-9705219e306f) - [Novartis Pharmaceuticals Corporation](https://www.keypedia.com/companies/novartis-pharmaceuticals-corporation/21559fd5-35ed-4cbd-b228-623dd76bcf47) - [Emergent Biodefense Operations Lansing LLC](https://www.keypedia.com/companies/emergent-biodefense-operations-lansing-llc/7a502584-4071-4f7a-bb11-7272db98f478) - [Indoco Remedies Limited](https://www.keypedia.com/companies/indoco-remedies-limited/00606519-7338-4109-b20b-b6858eae2f03) ## Related Officers - [Roseline N. Boateng](https://www.keypedia.com/people/roseline-n-boateng/81c4fa2a-1f0b-4e13-ba45-39ca7a07d3b3) - [William Leonard](https://www.keypedia.com/people/william-leonard/1f11ece4-597c-4d3e-aac4-46f8ea404ec3) - [President at Genpact](https://www.keypedia.com/people/damon-a-growl/b2827f8c-e454-4db3-9285-07d11b964d5a) - [Wang Zheng](https://www.keypedia.com/people/wang-zheng/3c622db3-8f40-416a-8ef3-0dce8c2ede12) - [recipient](https://www.keypedia.com/people/vijay-ramanavarapu/55c5fcb1-ee2d-49c3-b9b7-d3d3b9d4a705)